Literature DB >> 1717380

Neuroimmunomodulation in the intestinal mucosa.

C A Ottaway1.   

Abstract

The intestine contains major subdivisions of the nervous and immune systems. The lymphoid compartments of the intestine contain functionally distinguishable populations of immunologic cells and are innervated differently. The lamina propria has an extensive network of nerves using the neuropeptides SOM, SP, and VIP. Subpopulations of T cells, B cells, cells of the monocyte/macrophage line, and several other immunologically relevant cells have the ability to recognize and respond to these neuropeptide signals. SOM, SP, and VIP can act as potent regulators of lymphoid cell proliferation and interleukin and immunoglobulin production. The unusual effector lymphocytes in the epithelial layer of the intestine can be exposed to SP and VIP, and their responses may be regulated by these peptides. In the organized lymphoid compartments such as Peyer's patches, the neuropeptides VIP and SP may regulate the accumulation or recirculation of affector lymphocytes from the central compartment of the immune system and their subsequent response to antigens. The large array of immunoregulatory effects that have been found with these neuropeptides suggest that local neurophysiologic signals in the intestinal lymphoid microenvironments can regulate selected aspects of immune responses. The intestine is likely to be a highly specialized venue for neuroimmunomodulation in intact animals, and this has important implications in the physiologic and pathologic responses of the gut. Further investigations of these regulatory pathways will lead to new concepts concerning neural-immune interactions in general and the regulation of mucosal immunology in particular.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717380

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  23 in total

Review 1.  Neuroimmune alterations of ENS functioning.

Authors:  L Bueno
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  The gastrointestinal immune system: Implications for the surgical patient.

Authors:  Joseph F Pierre; Rebecca A Busch; Kenneth A Kudsk
Journal:  Curr Probl Surg       Date:  2015-10-23       Impact factor: 1.909

3.  Bombesin recovers gut-associated lymphoid tissue and preserves immunity to bacterial pneumonia in mice receiving total parenteral nutrition.

Authors:  R C DeWitt; Y Wu; K B Renegar; B K King; J Li; K A Kudsk
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 4.  Impact of aging on gastrointestinal mucosal immunity.

Authors:  D L Schmucker; M F Heyworth; R L Owen; C K Daniels
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

5.  Bombesin improves adaptive immunity of the salivary gland during parenteral nutrition.

Authors:  Joseph F Pierre; Aaron F Heneghan; Xinying Wang; Drew A Roenneburg; Guy E Groblewski; Kenneth A Kudsk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-10-11       Impact factor: 4.016

6.  Bombesin Preserves Goblet Cell Resistin-Like Molecule β During Parenteral Nutrition but Not Other Goblet Cell Products.

Authors:  Rebecca A Busch; Aaron F Heneghan; Joseph F Pierre; Joshua C Neuman; Claire A Reimer; Xinying Wang; Michelle E Kimple; Kenneth A Kudsk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-05-01       Impact factor: 4.016

7.  Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease.

Authors:  H Yamamoto; K Morise; K Kusugami; A Furusawa; T Konagaya; Y Nishio; H Kaneko; K Uchida; H Nagai; T Mitsuma; H Nagura
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

Review 8.  Gastrointestinal immune and microbiome changes during parenteral nutrition.

Authors:  Joseph F Pierre
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-02-02       Impact factor: 4.052

9.  Gut Lymphocyte Phenotype Changes After Parenteral Nutrition and Neuropeptide Administration.

Authors:  Mark A Jonker; Aaron F Heneghan; John H Fechner; Joseph F Pierre; Yoshifumi Sano; Jinggang Lan; Kenneth A Kudsk
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

10.  Oral administration of rapamycin and cyclosporine differentially alter intestinal function in rabbits.

Authors:  V C Dias; K L Madsen; K E Mulder; M Keelan; R W Yatscoff; A B Thomson
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.